Sang‐Hyun Cho

Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club

Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex

Targeted Antitubercular Peptide Nanocarriers Prepared by Flash NanoPrecipitation with Hydrophobic Ion Pairing

Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments

<i>In Vitro</i>Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis

New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

Antimycobacterial Rufomycin Analogues from <i>Streptomyces atratus</i> Strain MJM3502

Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions

Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening

High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads

Suadimins A–C, Unprecedented Dimeric Quinoline Alkaloids with Antimycobacterial Activity from <i>Melodinus suaveolens</i>

Antimicrobial Lavandulylated Flavonoids from a Sponge-Derived Streptomyces sp. G248 in East Vietnam Sea

Residual Complexity Does Impact Organic Chemistry and Drug Discovery: The Case of Rufomyazine and Rufomycin

QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity

Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity

Mutation in <i>clpC1</i> encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in <i>Mycobacterium tuberculosis</i>

Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials

Arrival of Imidazo[2,1-<i>b</i>]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB

Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043

Bioautography with TLC-MS/NMR for Rapid Discovery of Anti-tuberculosis Lead Compounds from Natural Sources

Imidazo[1,2- <i>a</i> ]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection <i>In Vivo</i>

Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins

Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis

Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward <i>Mycobacterium tuberculosis</i>

Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045

Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis

The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo

<i>In Vitro</i> and <i>In Vivo</i> Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis

Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin